Abstract
A Combinatorial Investigation of the Response to Anti-angiogenic Therapy in Breast Cancer: New Strategies for Patient Selection and Opportunities for Reconsidering Anti-VEGF, Anti-PI3K and Checkpoint Inhibition
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have